Cargando…

Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome

Sézary syndrome (SS) is a form of cutaneous T-cell lymphoma (CTCL), demonstrating leukemic involvement of malignant T-cells. Known systemic sequelae of SS include hemophagocytic syndrome-induced anemia, normocytic anemia secondary to bone marrow infiltration, and pancytopenia. We report a patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Jake C, Jafry, Mustufa A, Soma, Lori, Shustov, Andrei, Shinohara, Michi M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260342/
https://www.ncbi.nlm.nih.gov/pubmed/34262820
http://dx.doi.org/10.7759/cureus.15482
_version_ 1783718801127243776
author Robertson, Jake C
Jafry, Mustufa A
Soma, Lori
Shustov, Andrei
Shinohara, Michi M
author_facet Robertson, Jake C
Jafry, Mustufa A
Soma, Lori
Shustov, Andrei
Shinohara, Michi M
author_sort Robertson, Jake C
collection PubMed
description Sézary syndrome (SS) is a form of cutaneous T-cell lymphoma (CTCL), demonstrating leukemic involvement of malignant T-cells. Known systemic sequelae of SS include hemophagocytic syndrome-induced anemia, normocytic anemia secondary to bone marrow infiltration, and pancytopenia. We report a patient with SS, initially demonstrating widespread morbilliform eruption, who presented with malignancy-related microangiopathic hemolytic anemia (MAHA). Our findings represent a novel presentation of SS that will inform the differential diagnosis and treatment of future SS patients presenting with anemia and thrombocytopenia.
format Online
Article
Text
id pubmed-8260342
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-82603422021-07-13 Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome Robertson, Jake C Jafry, Mustufa A Soma, Lori Shustov, Andrei Shinohara, Michi M Cureus Dermatology Sézary syndrome (SS) is a form of cutaneous T-cell lymphoma (CTCL), demonstrating leukemic involvement of malignant T-cells. Known systemic sequelae of SS include hemophagocytic syndrome-induced anemia, normocytic anemia secondary to bone marrow infiltration, and pancytopenia. We report a patient with SS, initially demonstrating widespread morbilliform eruption, who presented with malignancy-related microangiopathic hemolytic anemia (MAHA). Our findings represent a novel presentation of SS that will inform the differential diagnosis and treatment of future SS patients presenting with anemia and thrombocytopenia. Cureus 2021-06-06 /pmc/articles/PMC8260342/ /pubmed/34262820 http://dx.doi.org/10.7759/cureus.15482 Text en Copyright © 2021, Robertson et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Robertson, Jake C
Jafry, Mustufa A
Soma, Lori
Shustov, Andrei
Shinohara, Michi M
Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
title Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
title_full Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
title_fullStr Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
title_full_unstemmed Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
title_short Fatal Microangiopathic Hemolytic Anemia Due to Sézary Syndrome
title_sort fatal microangiopathic hemolytic anemia due to sézary syndrome
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260342/
https://www.ncbi.nlm.nih.gov/pubmed/34262820
http://dx.doi.org/10.7759/cureus.15482
work_keys_str_mv AT robertsonjakec fatalmicroangiopathichemolyticanemiaduetosezarysyndrome
AT jafrymustufaa fatalmicroangiopathichemolyticanemiaduetosezarysyndrome
AT somalori fatalmicroangiopathichemolyticanemiaduetosezarysyndrome
AT shustovandrei fatalmicroangiopathichemolyticanemiaduetosezarysyndrome
AT shinoharamichim fatalmicroangiopathichemolyticanemiaduetosezarysyndrome